A Rare Case of Giant Rhinophyma

Authors

  • Vladimír Bartoš Department of Pathology, Faculty Hospital in Žilina, Slovakia

DOI:

https://doi.org/10.66344/jpad.32.1.2022.1826

Abstract

Rhinophyma is a rare skin disease characterized by a disfiguring enlargement of the nose due to hyperplasia of sebaceous glands and underlying connective tissue. It is generally considered to be a final stage of untreated rosacea. This report describes a 79-year-old man manifested with a giant rinophyma measuring 7 cm in diameter. It grew for many years but the patient had not sought any dermatologic intervention. The lesion was completely removed by using sharp scalpel incision. Although rhinophyma is not a life-threatening condition, it can sometimes reach a huge size, with a negative effect on quality of life. Such cases are usually a consequence of patient's delay in seeking medical advice. In more pronounced lesions, a simple surgical removal under tumescent anestesia is an optimal treatment modality.

Downloads

Published

2022-03-29

How to Cite

1.
Bartoš V. A Rare Case of Giant Rhinophyma . J Pak Assoc Dermatol [Internet]. 2022Mar.29 [cited 2026Apr.12];32(1):183-6. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1826

Issue

Vol. 32 No. 1 (2022): January - March

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.